Abemaciclib
Beschrijving
Titel: Adding abemaciclib to fulvestrant delays disease progression and prolongs the survival of women with HR+/HER2 negative advanced breast cancer across treatment lines, with a particularly pronounced survival benefit in patients with poor prognostic features
Gepubliceerd: BJMO 2020, September
Copyright: 2020 © Ariez BV